| Influenza virus vaccine based on the conserved hemagglutinin stalk domain J Steel, AC Lowen, TT Wang, M Yondola, Q Gao, K Haye, A García-Sastre, ... MBio 1 (1), 10.1128/mbio. 00018-10, 2010 | 587 | 2010 |
| Type I and type II Fc receptors regulate innate and adaptive immunity A Pincetic, S Bournazos, DJ DiLillo, J Maamary, TT Wang, R Dahan, ... Nature immunology 15 (8), 707-716, 2014 | 539 | 2014 |
| Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome K Röltgen, AE Powell, OF Wirz, BA Stevens, CA Hogan, J Najeeb, ... Science immunology 5 (54), eabe0240, 2020 | 477 | 2020 |
| New-onset IgG autoantibodies in hospitalized patients with COVID-19 SE Chang, A Feng, W Meng, SA Apostolidis, E Mack, M Artandi, L Barman, ... Nature communications 12 (1), 5417, 2021 | 394 | 2021 |
| Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins TT Wang, GS Tan, R Hai, N Pica, E Petersen, TM Moran, P Palese PLoS pathogens 6 (2), e1000796, 2010 | 360 | 2010 |
| Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes TT Wang, GS Tan, R Hai, N Pica, L Ngai, DC Ekiert, IA Wilson, ... Proceedings of the National Academy of Sciences 107 (44), 18979-18984, 2010 | 358 | 2010 |
| IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity TT Wang, J Sewatanon, MJ Memoli, J Wrammert, S Bournazos, ... Science 355 (6323), 395-398, 2017 | 328 | 2017 |
| Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses N Pica, R Hai, F Krammer, TT Wang, J Maamary, D Eggink, GS Tan, ... Proceedings of the National Academy of Sciences 109 (7), 2573-2578, 2012 | 290 | 2012 |
| Proinflammatory IgG Fc structures in patients with severe COVID-19 S Chakraborty, J Gonzalez, K Edwards, V Mallajosyula, AS Buzzanco, ... Nature immunology 22 (1), 67-73, 2021 | 259 | 2021 |
| Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2 SCA Nielsen, F Yang, KJL Jackson, RA Hoh, K Röltgen, GH Jean, ... Cell host & microbe 28 (4), 516-525. e5, 2020 | 227 | 2020 |
| Anti-HA glycoforms drive B cell affinity selection and determine influenza vaccine efficacy TT Wang, J Maamary, GS Tan, S Bournazos, CW Davis, F Krammer, ... Cell 162 (1), 160-169, 2015 | 206 | 2015 |
| Signaling by antibodies: recent progress S Bournazos, TT Wang, R Dahan, J Maamary, JV Ravetch Annual review of immunology 35, 285-311, 2017 | 201 | 2017 |
| Unraveling the mystery of swine influenza virus TT Wang, P Palese Cell 137 (6), 983-985, 2009 | 179 | 2009 |
| PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models R Hai, M Schmolke, ZT Varga, B Manicassamy, TT Wang, JA Belser, ... Journal of virology 84 (9), 4442-4450, 2010 | 169 | 2010 |
| Seroevidence for H5N1 influenza infections in humans: meta-analysis TT Wang, MK Parides, P Palese Science 335 (6075), 1463-1463, 2012 | 158 | 2012 |
| The role and function of Fcγ receptors on myeloid cells S Bournazos, TT Wang, JV Ravetch Myeloid Cells in Health and Disease: A Synthesis, 405-427, 2017 | 155 | 2017 |
| Why do influenza virus subtypes die out? A hypothesis P Palese, TT Wang MBio 2 (5), 10.1128/mbio. 00150-11, 2011 | 148 | 2011 |
| Functional diversification of IgGs through Fc glycosylation TT Wang, JV Ravetch The Journal of clinical investigation 129 (9), 3492-3498, 2019 | 138 | 2019 |
| Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection SK Elledge, XX Zhou, JR Byrnes, AJ Martinko, I Lui, K Pance, SA Lim, ... Nature biotechnology 39 (8), 928-935, 2021 | 132 | 2021 |
| SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand? S Chakraborty, V Mallajosyula, CM Tato, GS Tan, TT Wang Advanced drug delivery reviews 172, 314-338, 2021 | 112 | 2021 |
Jeffrey RavetchRockefeller University確認したメール アドレス: rockefeller.edu
